10-Year Overview
|
2022 |
2021 |
2020 |
2019 |
2018 |
2017 |
2016 |
2015 |
2014 |
2013 |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Order situation |
|||||||||||
|
Order book1 |
EUR |
569.6 |
508.4 |
391.3 |
358.3 |
379.2 |
329.1 |
302.4 |
295.8 |
279.6 |
236.7 |
|
Income statement |
|||||||||||
|
Revenue |
EUR |
1,243.0 |
1,091.9 |
952.2 |
1,100.1 |
1,084.1 |
1,017.1 |
894.9 |
889.6 |
694.7 |
635.5 |
|
thereof EMEA |
EUR |
489.2 |
462.4 |
409.5 |
486.0 |
494.8 |
485.9 |
432.0 |
416.0 |
394.5 |
388.0 |
|
thereof Americas |
EUR |
574.2 |
456.8 |
385.5 |
450.8 |
441.5 |
411.3 |
381.6 |
395.3 |
237.8 |
191.5 |
|
thereof Asia-Pacific |
EUR |
179.6 |
172.8 |
157.2 |
163.4 |
147.8 |
119.9 |
81.3 |
78.2 |
62.5 |
56.0 |
|
Engineered Joining |
EUR |
698.8 |
620.7 |
552.6 |
665.5 |
684.6 |
638.2 |
535.9 |
540.3 |
481.0 |
443.9 |
|
Standardized Joining |
EUR |
535.3 |
464.3 |
395.5 |
430.2 |
393.8 |
372.3 |
354.5 |
344.1 |
211.5 |
193.6 |
|
Cost of materials ratio |
% |
48.0 |
45.8 |
43.8 |
43.4 |
43.6 |
41.2 |
39.4 |
40.8 |
41.7 |
42.4 |
|
Personnel cost ratio |
% |
24.9 |
26.1 |
31.3 |
27.5 |
25.9 |
26.5 |
27.3 |
26.3 |
27.1 |
26.7 |
|
Adjusted EBITA2 |
EUR |
106.9 |
122.5 |
54.6 |
144.8 |
173.2 |
174.5 |
157.5 |
156.3 |
121.5 |
112.6 |
|
Adjusted EBITA margin2 |
% |
8.6 |
11.2 |
5.7 |
13.2 |
16.0 |
17.2 |
17.6 |
17.6 |
17.5 |
17.7 |
|
EBITA |
EUR |
105.6 |
121.0 |
51.1 |
127.9 |
164.8 |
166.8 |
150.4 |
150.5 |
113.3 |
112.1 |
|
EBiTA margin |
% |
8.5 |
11.1 |
5.4 |
11.6 |
15.2 |
16.4 |
16.8 |
16.9 |
16.3 |
17.6 |
|
Adjusted EBIT2 |
EUR |
99.0 |
113.8 |
45.3 |
136.1 |
164.5 |
166.0 |
147.7 |
147.9 |
116.2 |
107.7 |
|
Adjusted EBIT margin2 |
% |
8.0 |
10.4 |
4.8 |
12.4 |
15.2 |
16.3 |
16.5 |
16.6 |
16.7 |
16.9 |
|
EBIT |
EUR |
76.5 |
92.1 |
20.1 |
96.7 |
133.5 |
137.8 |
120.0 |
124.8 |
97.8 |
99.5 |
|
EBIT margin |
% |
6.2 |
8.4 |
2.1 |
8.8 |
12.3 |
13.5 |
13.4 |
14.0 |
14.1 |
15.7 |
|
Financial result |
EUR |
-12.6 |
-12.4 |
– 14.8 |
– 15.5 |
– 11.7 |
– 16.1 |
– 14.6 |
– 17.2 |
–14.5 |
–15.6 |
|
Adjusted tax rate2 |
% |
35.2 |
28.6 |
20.3 |
27.1 |
24.9 |
30.0 |
28.9 |
32.1 |
33.3 |
32.6 |
|
Adjusted profit for the period2 |
EUR |
56.0 |
72.3 |
24.3 |
87.8 |
114.8 |
105.0 |
94.6 |
88.7 |
71.5 |
62.1 |
|
Adjusted earnings per share2 |
EUR |
1.75 |
2.27 |
0.77 |
2.76 |
3.61 |
3.29 |
2.96 |
2.78 |
2.24 |
1.95 |
|
Profit for the period |
EUR |
39.2 |
56.1 |
5.5 |
58.4 |
91.8 |
119.8 |
75.9 |
73.8 |
54.9 |
55.6 |
|
Earnings per share |
EUR |
1.23 |
1.76 |
0.18 |
1.83 |
2.88 |
3.76 |
2.38 |
2.31 |
1.72 |
1.74 |
|
NORMA Value Added |
EUR |
-27.1 |
16.0 |
– 46.4 |
17.3 |
60.8 |
54.9 |
53.1 |
48.3 |
n/a |
n/a |
|
Return on Capital Employed (ROCE)3 |
% |
9.7 |
11.9 |
4.6 |
13.0 |
17.2 |
18.9 |
17.7 |
19.3 |
n/a |
n/a |
|
R&D expense |
EUR |
40,6 |
38,0 |
29.0 |
31.2 |
30.5 |
29.4 |
28.8 |
25.4 |
25.7 |
21.9 |
|
R&D ration (related to sales) |
% |
3,3 |
3,5 |
3.1 |
4.7 |
4.5 |
4.6 |
5.4 |
4.7 |
5.3 |
4.9 |
|
Investment ratio in |
% |
4.3 |
4.3 |
4.3 |
5.0 |
5.8 |
4.7 |
5.4 |
4.7 |
5.7 |
4.8 |
|
Balance sheet1 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Total assets |
EUR |
1,560.7 |
1,498.2 |
1,414.7 |
1,514.3 |
1,471.7 |
1,312.0 |
1,337.7 |
1,167.9 |
1,078.4 |
823.7 |
|
Equity |
EUR |
705.4 |
668.6 |
589.5 |
629.5 |
602.4 |
534.3 |
483.6 |
429.8 |
368.0 |
319.9 |
|
Equity ratio |
% |
45.2 |
44.6 |
41.7 |
41.6 |
40.6 |
40.7 |
36.2 |
36.8 |
34.1 |
38.8 |
|
Net debt |
EUR |
349.8 |
318.5 |
338.4 |
420.8 |
400.3 |
344.9 |
394.2 |
360.9 |
373.1 |
153.5 |
|
Working capital |
EUR |
230.4 |
189.5 |
160.8 |
192.5 |
179.2 |
158.2 |
144.5 |
151.9 |
141.8 |
110.8 |
|
Working capital related |
% |
18.5 |
17.4 |
16.9 |
17.5 |
16.5 |
15.6 |
16.1 |
17.1 |
20.4 |
17.4 |
|
Cash flow |
|||||||||||
|
Cash flow from |
EUR |
76.6 |
108.4 |
133.5 |
137.1 |
130.8 |
146.0 |
149.2 |
128.2 |
96.4 |
115.4 |
|
Cash flow from |
EUR |
-44.5 |
-45.2 |
– 39.1 |
– 57.0 |
– 129.5 |
– 70.8 |
-133.8 |
– 44.5 |
– 265.1 |
– 43.4 |
|
Cash flow from |
EUR |
-54.5 |
-71.1 |
– 81.0 |
– 93.2 |
31.3 |
– 77.7 |
49.6 |
– 70.4 |
57.7 |
51.7 |
|
Net operating cash |
EUR |
65.3 |
99.8 |
78.3 |
122.9 |
124.4 |
132.9 |
148.5 |
134.7 |
109.2 |
103.9 |
|
Non financial figures |
|||||||||||
|
Core workforce1 |
6,175 |
6,191 |
6,635 |
6,523 |
6,901 |
6,115 |
5,450 |
5,121 |
4,828 |
4,134 |
|
|
Temporary workers1 |
2,532 |
2,012 |
2,155 |
1,998 |
1,964 |
1,552 |
1,214 |
1,185 |
1,147 |
813 |
|
|
Total workforce1 |
8,707 |
8,203 |
8,790 |
8,521 |
8,865 |
7,667 |
6,664 |
6,306 |
5,975 |
4,947 |
|
|
Number of invention applications1 |
21 |
25 |
22 |
22 |
32 |
33 |
k.A. |
k.A. |
k.A. |
k.A. |
|
|
Defective parts |
Parts/ |
2.9 |
4.9 |
5.1 |
6.1 |
7.1 |
16.1 |
32,0 |
k.A. |
k.A. |
k.A. |
|
Average customer |
3.7 |
5.1 |
4.7 |
6.4 |
7.0 |
9.0 |
8.0 |
k.A. |
k.A. |
k.A. |
|
|
CO2 emissions (Scope 1 and 2)6 |
t CO2 |
4,879 |
43,449 |
49,875 |
54,494 |
51,018 |
k.A. |
k.A. |
k.A. |
k.A. |
k.A. |
|
Share data |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Last price1, 7 |
EUR |
17.00 |
33.88 |
41.90 |
38.00 |
43.20 |
56.00 |
40.60 |
51.20 |
39.60 |
36.10 |
|
Market capitalization1, 7 |
EUR |
542 |
1,079 |
1,334 |
1,211 |
1,376 |
1,783 |
1,292 |
1,630 |
1,263 |
1,150 |
|
Dividend8 |
EUR |
0.55 |
0.75 |
0.70 |
0.04 |
1.10 |
1.05 |
0.95 |
0.90 |
0.75 |
0.70 |
|
Payout ratio8 |
% |
31.3 |
33.0 |
91.7 |
1.5 |
30.5 |
31.9 |
32.0 |
32.3 |
33.4 |
35.9 |
|
Price-earnings ratio |
13.8 |
19.3 |
232.7 |
20.8 |
15.0 |
14.9 |
17.0 |
22.1 |
23.0 |
20.7 |
|
|
Number of shares |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
31,862,400 |
|
|
1_Figures as of balance sheet date Dec 31. 2_Since 2020: Adjusted exclusively for expenses related to acquisitions; Prior years: Adjusted for expenses related to acquisitions and non-recurring items. Details regarding the adjustments can be found in the corresponding Annual Reports. 3_Adjusted EBIT in relation to the average capital employed. 4_Until 2019: in relation to EJT sales, since 2020: in relation to total sales. 5_The number of invention applications has served as a key control parameter for measuring the Group’s innovative ability since mid-2016, replacing the number of patent applications, a figure that had lost significance in light of changes in the patent strategy. There are no comparative figures for prior years. 6_Since 2017, CO2 emissions have been reported according to the requirements of the Greenhouse Gas Protocol. The figures relating to the years 2019 and before are audited with “limited assurance”. 7_Xetra price. 8_Subject to approval by the Annual General Meeting. |
|||||||||||
Legend
These contents are part of the Non-financial Group Report and were subject to a separate limited assurance examination.